XML 33 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Pay vs Performance Disclosure [Table]      
Pay vs Performance [Table Text Block]
Fiscal Year
Summary Compensation Table Total for PEO
(1)		Compensation Actually Paid to PEO
(2)		Average Summary Compensation Table Total for non-PEO NEOs
(3)		Average Compensation Actually Paid to non-PEO NEOs
(4)		Value of Initial Fixed $100
Investment Based On:		Net Income ($M)
Adjusted Net Sales ($M)
(6)
RMD Total Shareholder Return
Dow Jones US Med. Equipment Total Shareholder Return
(5)
2023$13,868,641$16,867,038$4,147,542$4,909,275$113.80$129.79$897.6$4,163.2
2022$11,659,215$4,374,620$3,625,326-$55,486$109.18$114.04$779.4$3,616.1
2021$10,389,326$32,799,199$4,165,235$12,203,786$128.40$135.10$474.5$3,174.3
    
Company Selected Measure Name Adjusted Net Sales    
Named Executive Officers, Footnote [Text Block] ResMed had one Principal Executive Officer or “PEO”, Mr. Michael Farrell, during fiscal years 2023, 2022, and 2021.Non-PEO NEOs included for the fiscal years 2023, 2022 and 2021 are reflected in the table below:
Fiscal YearNon-PEO NEOs
2023Lucile Blaise, Rob Douglas, Bobby Ghoshal, Brett Sandercock
2022Rob Douglas, Bobby Ghoshal, Jim Hollingshead, David Pendarvis, Brett Sandercock
2021Rob Douglas, Jim Hollingshead, Brett Sandercock, Raj Sodhi
    
Peer Group Issuers, Footnote [Text Block] .     The Dow Jones U.S. Medical Equipment index is one of the two index peer groups disclosed in our 10-K and we selected this index as our peer group for purposes of this disclosure, which is comprised of 61 companies from the Dow Jones U.S. Broad Stock Market Index that are classified in the DJICS Medical Equipment subsection. The Company’s fiscal 2023 performance-based long-term incentive program did not use this relative TSR as a financial performance measure. See the CD&A section titled “Long Term Incentives” in this Proxy Statement for additional information.    
PEO Total Compensation Amount $ 13,868,641 $ 11,659,215 $ 10,389,326
PEO Actually Paid Compensation Amount $ 16,867,038 4,374,620 32,799,199
Adjustment To PEO Compensation, Footnote [Text Block] SEC rules require certain adjustments be made to the “Total” column as reported in the Summary Compensation Table to determine “Compensation Actually Paid” as reported in the Pay versus Performance Table (“PVP Table”). “Compensation Actually Paid” does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules. The equity values are calculated in accordance with ASC Topic 718, with dividends being reflected in the fair value of the award. Valuation assumptions used to calculate fair values used a consistent process as done on the date of grant and were not materially different from those disclosed at the time of grant. The closing stock price of our common stock on June 30, 2020, June 30, 2021, June 30, 2022, and June 30, 2023, was $192.00, $246.52, $209.63 and $218.50. The following tables detail these adjustments for the PEO:
PEO
Prior FYE6/30/20206/30/20216/30/2022
Current FYE6/30/20216/30/20226/30/2023
Fiscal Year202120222023
Summary Compensation Table Total$10,389,326$11,659,215$13,868,641
- Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year$(7,700,011)$(9,000,005)$(10,999,975)
+ Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year$9,967,171$6,170,624$10,216,009
+ Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years$15,351,855$(5,637,001)$(1,315,735)
+ Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year$—$—$—
+ Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year$4,790,858$1,181,787$5,098,098
- Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year$—$—$—
Total Adjustments$22,409,873$(7,284,595)$2,998,397
Compensation Actually Paid$32,799,199$4,374,620$16,867,038
    
Non-PEO NEO Average Total Compensation Amount $ 4,147,542 3,625,326 4,165,235
Non-PEO NEO Average Compensation Actually Paid Amount $ 4,909,275 (55,486) 12,203,786
Adjustment to Non-PEO NEO Compensation Footnote [Text Block] 4.     As discussed in footnote 2, SEC rules require certain adjustments to be made to determine “compensation actually paid” as reported in the Pay versus Performance table above. The following table details these adjustments to the Average Summary Compensation Table Total for Non-PEO NEOs.
Average of Non-PEO NEOs
Prior FYE6/30/20206/30/20216/30/2022
Current FYE6/30/20216/30/20226/30/2023
Fiscal Year202120222023
Summary Compensation Table Total$4,165,235$3,625,326$4,147,542
- Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year$(2,775,010)$(2,500,046)$(2,821,097)
+ Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year$3,708,490$1,328,777$2,643,811
+ Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years$5,495,623$(1,432,485)$(346,310)
+ Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year$—$—$—
+ Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year$1,609,448$390,289$1,285,329
- Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year$—$(1,467,347)$—
Total Adjustments$8,038,551$(3,680,812)$761,733
Compensation Actually Paid$12,203,786$(55,486)$4,909,275
    
Tabular List [Table Text Block]
Financial Performance Measures
Adjusted Net Sales
Net Operating Profit
Total Shareholder Return (TSR)
    
Total Shareholder Return Amount $ 113.80 109.18 128.40
Peer Group Total Shareholder Return Amount 129.79 114.04 135.10
Net Income (Loss) $ 897,600,000 $ 779,400,000 $ 474,500,000
Company Selected Measure Amount 4,163,200,000 3,616,100,000 3,174,300,000
PEO Name Mr. Michael Farrell    
Measure [Axis]: 1      
Pay vs Performance Disclosure [Table]      
Measure Name Adjusted Net Sales    
Non-GAAP Measure Description [Text Block] .     Adjusted Net Sales represents the most important financial performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link compensation actually paid to our NEOs, including our CEO, for the most recently completed fiscal year to the Company’s performance. Adjusted Net Sales is a non-GAAP measure and is calculated as net sales on a GAAP basis excluding the impact of revenue from acquisitions completed after the establishment of the internal financial plan, as applicable, and foreign currency fluctuations. For a reconciliation of Adjusted Net Sales to the most directly comparable GAAP financial measure and insight into how Adjusted Net Sales is considered by management, please see Page 56 under "Elements of Compensation - Annual Cash Incentive Plan - Incentive Plan Adjustments."    
Measure [Axis]: 2      
Pay vs Performance Disclosure [Table]      
Measure Name Net Operating Profit    
Measure [Axis]: 3      
Pay vs Performance Disclosure [Table]      
Measure Name Total Shareholder Return (TSR)    
PEO [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ 2,998,397 $ (7,284,595) $ 22,409,873
PEO [Member] | Equity Awards Reported Value [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (10,999,975) (9,000,005) (7,700,011)
PEO [Member] | Equity Awards Granted During the Year, Unvested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 10,216,009 6,170,624 9,967,171
PEO [Member] | Equity Awards Granted in Prior Years, Unvested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (1,315,735) (5,637,001) 15,351,855
PEO [Member] | Equity Awards Granted During the Year, Vested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 0 0
PEO [Member] | Equity Awards Granted in Prior Years, Vested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 5,098,098 1,181,787 4,790,858
PEO [Member] | Equity Awards that Failed to Meet Vesting Conditions [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 0 0
Non-PEO NEO [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 761,733 (3,680,812) 8,038,551
Non-PEO NEO [Member] | Equity Awards Reported Value [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (2,821,097) (2,500,046) (2,775,010)
Non-PEO NEO [Member] | Equity Awards Granted During the Year, Unvested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 2,643,811 1,328,777 3,708,490
Non-PEO NEO [Member] | Equity Awards Granted in Prior Years, Unvested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (346,310) (1,432,485) 5,495,623
Non-PEO NEO [Member] | Equity Awards Granted During the Year, Vested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 0 0
Non-PEO NEO [Member] | Equity Awards Granted in Prior Years, Vested [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 1,285,329 390,289 1,609,448
Non-PEO NEO [Member] | Equity Awards that Failed to Meet Vesting Conditions [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ 0 $ (1,467,347) $ 0